Staff News Writer

New proposed rules from the Centers for Medicare & Medicaid Services (CMS) would impact many aspects of physician payment and federal regulatory programs, but many of these changes are not for the better. In a letter sent last week, the AMA urged the agency to make revisions to avoid negative effects on physicians and patients.

A new timeline the Centers for Medicare & Medicaid Services (CMS) plans to implement for reviewing new, revised and potentially misvalued services could significantly slow the timeframe for implementing important CPT® code updates and changes to the values of physician services.

From his unique position to learn about groundbreaking research, Dr. Bauchner walks physicians through what’s to come in the future—and how to manage changes in preparing for that care in an AMA “Innovations in Medicine” talk.

At-risk seniors in a Florida community are getting some extra help with preventing the onset of type 2 diabetes. About half of all U.S. adults aged 65 years or older have prediabetes, the precursor to diabetes, according to the Centers for Disease Control and Prevention (CDC).

Following recent adoption of the veterans’ health care reform law, the U.S. Department of Veterans Affairs (VA) is reaching out to physicians in private practice to make sure veterans have access to timely medical care.

Most of the 11 schools that received grants in the AMA’s Accelerating Change in Medical Education initiative are investigating how to teach systems-based practice, a blanket term that can cover systems of care, quality improvement, population health and other competencies that would fall under the science of health care delivery.

The way care is delivered can have drastic effects on patients’ health, even in the treatment of the same illness. One physician shares her experience in the differences between fee-for-service and value-based care, and how these differences have directly affected her patients’ health outcomes.

Less than two weeks remain for physicians to review and dispute data about their financial interactions with medical device and drug manufacturers before the information goes public Sept. 30.